97 related articles for article (PubMed ID: 6940655)
1. Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients.
Nagel JE; Collins GD; Adler WH
Cancer Res; 1981 Jun; 41(6):2284-8. PubMed ID: 6940655
[TBL] [Abstract][Full Text] [Related]
2. Age- and sex-dependent changes in natural killer cell activity.
Hu C; Scorza Smeraldi R; Radelli L; Fabio G; Vanoli M; Zanussi C
Boll Ist Sieroter Milan; 1987; 66(4):289-96. PubMed ID: 3442619
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
4. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
Tanaka Y
Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
[No Abstract] [Full Text] [Related]
5. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
6. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.
Decker JM; Hinson A; Ades EW
J Clin Lab Immunol; 1984 Nov; 15(3):137-43. PubMed ID: 6397595
[TBL] [Abstract][Full Text] [Related]
8. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
Hagner G
Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
[TBL] [Abstract][Full Text] [Related]
9. The effect of blood donation on natural killer activity in man.
Lasek W; Plodziszewska M; Jakobisiak M
J Clin Lab Immunol; 1987 Apr; 22(4):165-8. PubMed ID: 3612753
[TBL] [Abstract][Full Text] [Related]
10. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
11. Ethanol and natural killer cells. I. Activity and immunophenotype in alcoholic humans.
Cook RT; Li F; Vandersteen D; Ballas ZK; Cook BL; LaBrecque DR
Alcohol Clin Exp Res; 1997 Sep; 21(6):974-80. PubMed ID: 9309304
[TBL] [Abstract][Full Text] [Related]
12. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
13. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha.
Kutza J; Murasko DM
Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259
[TBL] [Abstract][Full Text] [Related]
14. Impaired oxidative burst does not affect human monocyte tumoricidal activity.
Chen AR; Koren HS
J Immunol; 1985 Mar; 134(3):1909-13. PubMed ID: 2981928
[TBL] [Abstract][Full Text] [Related]
15. Compensatory effect of TNFalpha on low natural killer activity in the elderly.
Myśliwska J; Bryl E; Trzonkowski P; Myśliwski A
Acta Biochim Pol; 2000; 47(2):301-11. PubMed ID: 11051195
[TBL] [Abstract][Full Text] [Related]
16. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
[TBL] [Abstract][Full Text] [Related]
18. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women.
Stopińska-Głuszak U; Waligóra J; Grzela T; Głuszak M; Jóźwiak J; Radomski D; Roszkowski PI; Malejczyk J
J Reprod Immunol; 2006 Feb; 69(1):65-75. PubMed ID: 16236362
[TBL] [Abstract][Full Text] [Related]
20. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
Colquhoun SD; Economou JS; Shau H; Golub SH
J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
